<?xml version="1.0" encoding="UTF-8"?>
<p>Over the last two decades, non-fused pyridazine nucleus has emerged as an important class of heterocycles that represents a promising and privileged scaffold in medicinal chemistry
 <xref rid="CIT0010" ref-type="bibr">
  <sup>10</sup>
 </xref>. Literature survey revealed that plenty of pyridazine-based small molecules have been extensively investigated for a broad array of significant biological actions, such as anti-inflammatory
 <xref rid="CIT0011" ref-type="bibr">
  <sup>11</sup>
 </xref>
 <sup>,</sup>
 <xref rid="CIT0012" ref-type="bibr">
  <sup>12</sup>
 </xref>, anti-hypertensive
 <xref rid="CIT0013" ref-type="bibr">
  <sup>13</sup>
 </xref>, anti-diabetic
 <xref rid="CIT0014" ref-type="bibr">
  <sup>14</sup>
 </xref>, anti-obesity
 <xref rid="CIT0015" ref-type="bibr">
  <sup>15</sup>
 </xref>, neuroprotective
 <xref rid="CIT0016" ref-type="bibr">
  <sup>16</sup>
 </xref>, anti-Alzheimerâ€™s
 <xref rid="CIT0017" ref-type="bibr">
  <sup>17</sup>
 </xref>, anti-tubercular
 <xref rid="CIT0018" ref-type="bibr">
  <sup>18</sup>
 </xref>, anti-HIV
 <xref rid="CIT0019" ref-type="bibr">
  <sup>19</sup>
 </xref> and anticancer
 <xref rid="CIT0020" ref-type="bibr">
  <sup>20</sup>
 </xref> activities.
</p>
